Morgan Stanley retains overweight on Can Fin Homes with Rs 800 target after Q4 PAT beats estimates
By News Desk Published on April 24, 2025, 09:07 IST
Morgan Stanley has maintained an overweight rating on Can Fin Homes, with a target price of Rs 800, following a stronger-than-expected performance in the fourth quarter of FY25. Profit after tax (PAT) stood at Rs 2.4 billion , coming in 8% above Morgan Stanley estimates.
Pre-provision operating profit (PPOP) rose 8% YoY , which was 1% higher than estimates.
The PAT beat was primarily driven by a lower tax rate .
Loan growth was reported at 9% YoY and 3% QoQ .
Disbursements came in at Rs 24.6 billion , reflecting a 31% YoY and 6% QoQ increase, aligned with the company's guidance.
The brokerage noted that the management's outlook on FY26 loan growth will be a key monitorable going forward.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Always consult with a qualified financial advisor before making investment decisions.
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
an hour ago
- Business Upturn
Zen Technologies shares in focus after introducing Four-Barrel Rotary Machine Gun
Zen Technologies shares are in focus today after introducing its Four-Barrel Rotary Machine Gun, designed for counter-drone and high-intensity combat operations. The weapon features a rapid firing rate of up to 3,500 rounds per minute and an electronically operated firing mechanism, positioning it as a cutting-edge solution in modern warfare. Zen Technologies (@ZenTechnologies) Four-Barrel Rotary Machine Gun Featuring a firing rate of up to 3,500 rounds/min and dependable electronic operation, it stands as the premier weapon for counter-drone operations and intense combat scenarios. — Alpha Defense™🇮🇳 (@alpha_defense) June 10, 2025 The stock opened at ₹2,030.90 and touched an intraday high of ₹2,057.90, before slipping to a low of ₹2,015.00. It remains significantly below its 52-week high of ₹2,627.00 but well above the 52-week low of ₹945.35. As of 11:50 AM, the shares were trading 0.56% higher at Rs 2,025.00. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Business Insider
2 hours ago
- Business Insider
Will Coca-Cola (KO) Expand Its Market Dominance With the Return of a Favorite Flavor?
Coca-Cola (KO) is reportedly planning to bring back a fan-favorite flavor, as it looks to expand its dominance of the U.S. soda market. New reports suggest that the beverage company will return Diet Cherry Coke to store shelves. Confident Investing Starts Here: The reports don't claim when this return will happen, but do note that Diet Cherry Coke will only be around for a limited time. Leaks show a retro-inspired can and packaging for the promotion. Coca-Cola fans have called on the company to revive Diet Cherry Coke after it was discontinued five years ago. The company has instead focused on its Coke Zero Sugar line of drinks, but sales of those still fall behind their Diet Coke variants. With that in mind, it makes sense that Coca-Cola would bring back a classic flavor to meet the demand for its diet drinks. Coca-Cola Stock Analyst Coverage In related news, there's new analyst coverage of KO stock that will please shareholders. Five-star Morgan Stanley analyst Dara Mohsenian reiterated a Buy rating and $81 price target for Coca-Cola stock, implying a 13.3% upside for the shares. KO stock was also up 0.28% as of Monday afternoon. While not a major increase, baby steps to giant strides have resulted in a 15.78% rise year-to-date. This has resulted in the stock outperforming the major indices even in light of inflation, tariffs, and other economic headwinds. Is Coca-Cola Stock a Buy, Sell, or Hold? Turning to Wall Street, the analysts' consensus rating for Coca-Cola is Strong Buy, based on 14 Buy and one Hold rating over the past three months. With that comes an average KO stock price target of $79.50, representing a potential 11.09% upside for the shares.
Business Upturn
3 hours ago
- Business Upturn
OneSource Specialty Pharma shares jump 3% after USFDA grants VAI classification for its Bangalore facility
By Aman Shukla Published on June 10, 2025, 09:22 IST Shares of OneSource Specialty Pharma Ltd jumped 3% in morning trade on June 10 after the company announced that its flagship facility in Bangalore received a 'Voluntary Action Indicated' (VAI) classification from the U.S. Food and Drug Administration (USFDA). As of 9:21 AM, the shares were trading 3.61% higter at Rs 2,002.70. The classification follows a routine USFDA inspection conducted from March 20 to March 28, 2025. At the end of the inspection, the agency issued a Form 483 with four observations. The company responded with a comprehensive corrective action plan. After reviewing the response, the USFDA designated the outcome as VAI, indicating that while issues were noted, they were not serious enough to trigger regulatory or enforcement action. The VAI status also confirms that the inspection is now officially closed. The company did not disclose the specific details of the observations, but emphasized that the facility remains integral to its core manufacturing and development operations. A VAI classification is generally seen as a positive regulatory outcome, especially compared to more severe classifications like 'Official Action Indicated' (OAI). Investors reacted favorably to the news, pushing the stock higher. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
